Abstract

Aloe vera, historically acclaimed as the plant of immortality, has gained significant attention for its therapeutic potential, particularly in dermatology and anti-inflammatory applications. In this study, we use a computational approach that integrates molecular docking analysis and pharmacokinetic assessment to explore the inhibitory potential of aloe vera phytochemicals against tumor necrosis factoralpha, a key inflammatory protein implicated in various pathologies, including rheumatoid arthritis. The in silico screening identified top-performing compounds, with aloesin emerging as a promising inhibitor. Pharmacological analyses revealed aloesin's favourable toxicity profile, positioning it as a promising candidate for further drug development. This research provides insights into the anti-inflammatory properties of aloesin in Aloe vera, paving the way for future experimental validations and the development of novel therapeutics for rheumatoid arthritis.